VLY:NASDAQValley National Bancorp Analysis
Data as of 2026-05-09 - not real-time
$13.41
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Valley National Bancorp (VLY) is trading just above its 20‑day SMA of 13.42 and comfortably above the 50‑day SMA of 12.73, signaling a continued bullish bias despite a modestly bearish MACD histogram. The stock sits near the calculated support level of 12.86 with resistance at 14.12, offering a clear upside corridor that aligns with analyst consensus target prices around 16.00, implying roughly 17% upside. Fundamentals reinforce the technical case: revenue grew 23.8% YoY, profit margins exceed 33%, and the forward P/E of 8.8 is well below the industry average of 16.4, indicating the stock is undervalued. The dividend yield of 3.28% with a payout ratio under 40% adds income appeal, and the recent Q1 earnings beat—sales up 12.6% and non‑GAAP EPS surpassing expectations—demonstrates momentum in the bank’s commercial expansion.
The risk profile is tempered by a beta above 1.2 and a 30‑day volatility near 27%, reflecting heightened sensitivity to broader market swings and the regional banking sector’s credit environment. Volume trends are decreasing, suggesting a modest liquidity concern, while the bank’s strong cash position relative to debt and a solid dividend track record keep the dividend sustainability outlook positive. Overall, VLY presents a compelling blend of value and growth characteristics, making it an attractive buy for investors seeking both capital appreciation and dividend income.
The risk profile is tempered by a beta above 1.2 and a 30‑day volatility near 27%, reflecting heightened sensitivity to broader market swings and the regional banking sector’s credit environment. Volume trends are decreasing, suggesting a modest liquidity concern, while the bank’s strong cash position relative to debt and a solid dividend track record keep the dividend sustainability outlook positive. Overall, VLY presents a compelling blend of value and growth characteristics, making it an attractive buy for investors seeking both capital appreciation and dividend income.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support with bullish SMA alignment
- Recent earnings beat supporting short‑term confidence
- Elevated volatility and decreasing volume caution rapid moves
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation metrics (low forward P/E, P/B ~1)
- Strong revenue growth and high profit margins
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistent earnings growth and expanding commercial franchise
- Solid balance sheet with cash buffer despite debt level
- Long‑term upside potential toward analyst target price and dividend income
Key Metrics & Analysis
Financial Health
Revenue Growth23.80%
Profit Margin33.79%
P/E Ratio12.1
ROE8.56%
ROA1.04%
P/B Ratio1.0
Industry P/E16.4
Technical Analysis
TrendBullish
RSI54.1
Support$12.86
Resistance$14.12
MA 20$13.42
MA 50$12.73
MA 200$11.57
MACDBearish
VolumeDecreasing
Fear & Greed Index90.73
Valuation
Target Price$15.71
Upside/Downside17.18%
GradeUndervalued
TypeBlend
Dividend Yield3.28%
Risk Assessment
Beta1.23
Volatility26.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.